Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

GlaxoSmithKline Pakistan

Market Cap: PK₨122.7b

Operates as a biopharma company in Pakistan.

Innovent Biologics

Market Cap: HK$143.3b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Abbott India

Market Cap: ₹595.8b

Operates as a pharmaceutical company in India.

Chimeric Therapeutics

Market Cap: AU$10.9m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

Vitrolife

Market Cap: SEK 18.0b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Eurofins Scientific

Market Cap: €10.9b

Provides various analytical testing and laboratory services worldwide.

hVIVO

Market Cap: UK£50.0m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Neimeth International Pharmaceuticals

Market Cap: ₦26.3b

Manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana.

UCB

Market Cap: €45.8b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Eledon Pharmaceuticals

Market Cap: US$118.0m

Operates as a clinical stage biotechnology company.

NRx Pharmaceuticals

Market Cap: US$61.3m

A clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder, and chronic pain.

Bruker

Market Cap: US$6.8b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

TuHURA Biosciences

Market Cap: US$45.5m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Ironwood Pharmaceuticals

Market Cap: US$530.3m

A biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally.

Solid Biosciences

Market Cap: US$411.4m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Kairos Pharma

Market Cap: US$16.1m

A clinical-stage biopharmaceutical company, develops therapeutics for cancer patients.

SIGA Technologies

Market Cap: US$451.9m

A commercial-stage pharmaceutical company, focuses on the health security market in the United States.

Black Diamond Therapeutics

Market Cap: US$144.7m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

Greenwich LifeSciences

Market Cap: US$171.7m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers in the United States and Romania.

Inotiv

Market Cap: US$22.2m

Provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally.

Verrica Pharmaceuticals

Market Cap: US$129.7m

A dermatology therapeutics company, engages in the development and sale of medications for the treatment of skin diseases in the United States.

Elutia

Market Cap: US$23.2m

A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.

Innoviva

Market Cap: US$1.5b

Engages in the development and commercialization of pharmaceutical products in the United States and internationally.

MTL Cannabis

Market Cap: CA$97.4m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

Senores Pharmaceuticals

Market Cap: ₹37.1b

Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.

Bavarian Nordic

Market Cap: DKK 14.8b

Develops, manufactures, and supplies life-saving vaccines.

Basilea Pharmaceutica

Market Cap: CHF 657.4m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.

Aardvark Therapeutics

Market Cap: US$298.1m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

Cognition Therapeutics

Market Cap: US$132.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina.

Aytu BioPharma

Market Cap: US$25.2m

A pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally.

Jasper Therapeutics

Market Cap: US$52.1m

A clinical-stage biotechnology company, focuses on developing therapeutics targeting mast and hematopoietic stem cell driven diseases.

KALA BIO

Market Cap: US$6.2m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.

Inhibrx Biosciences

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

ADC Therapeutics

Market Cap: US$483.1m

Provides antibody drug conjugate (ADC) technology platform to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

IQVIA Holdings

Market Cap: US$37.9b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Palvella Therapeutics

Market Cap: US$1.1b

A clinical-stage biopharmaceutical company, focuses on developing and commercializing novel therapies to treat patients serious and rare genetic skin diseases.